Yesterday, a Director at Cigna (CI), Eric Foss, bought shares of CI for $1.99M.
Following this transaction Eric Foss’ holding in the company was increased by 89.61% to a total of $5.02 million. This is Foss’ first transaction since reporting a Buy transaction on ARMK back in December 2018
See today’s analyst top recommended stocks >>
The company has a one-year high of $216.78 and a one-year low of $141.95. CI’s market cap is $73.04B and the company has a P/E ratio of 17.19.
Eight different firms, including BMO Capital and Citigroup, currently also have a Buy rating on the stock. Starting in November 2019, CI received 6 Buy ratings in a row.
In the last 30 days, insiders have sold $1.76M worth of CI shares and purchased $1.99M worth of CI shares. The insider sentiment on Cigna has been negative according to 42 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Cigna Corp. is a global health service company, which is dedicated to improving the health, well-being and peace of mind. Its products and services include an integrated suite of health services such as medical, dental, behavioral health, pharmacy, vision, supplemental benefits and other related products including group life, accident and disability insurance. The company was founded in 1792 and is headquartered in Bloomfield, CT.
Read More on CI:
